Proheptazine is an opioid analgesic related to pethidine. It was invented in the 1960s.[2]
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ECHA InfoCard | 100.000.916 |
Chemical and physical data | |
Formula | C17H25NO2 |
Molar mass | 275.392 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(verify) |
Proheptazine produces similar effects to other opioids,[3] including analgesia, sedation, euphoria, dizziness and nausea.
In the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9643 and a 2013 annual aggregate manufacturing quota of zero. The salts in use are the citrate (free base conversion ratio 0.589), hydrobromide (0.773), and hydrochloride (0.883).[4][5]